MART-1 (26-35) (human) TFA, an epitope peptide, is indispensably employed in the realm of biomedical research aimed at immunotherapy advancements. Proficiently directed at melanoma antigens, it exerts an influential impact on inciting the immune system's response against the malignant melanoma cells, thus exhibiting its paramount significance in fostering groundbreaking therapeutic interventions tailored for afflicted melanoma subjects.
CAT No: GR2200
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More